Logo image of AGLX.OL

AGILYX ASA (AGLX.OL) Stock Fundamental Analysis

OSL:AGLX - Euronext Oslo - NO0010872468 - Common Stock - Currency: NOK

26  -0.1 (-0.38%)

Fundamental Rating

5

Taking everything into account, AGLX scores 5 out of 10 in our fundamental rating. AGLX was compared to 43 industry peers in the Commercial Services & Supplies industry. No worries on liquidiy or solvency for AGLX as it has an excellent financial health rating, but there are worries on the profitability. AGLX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AGLX had positive earnings in the past year.
AGLX had a negative operating cash flow in the past year.
AGLX had negative earnings in 4 of the past 5 years.
In the past 5 years AGLX always reported negative operating cash flow.
AGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFAGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

1.2 Ratios

AGLX has a better Return On Assets (72.71%) than 97.67% of its industry peers.
AGLX's Return On Equity of 76.52% is amongst the best of the industry. AGLX outperforms 97.67% of its industry peers.
Industry RankSector Rank
ROA 72.71%
ROE 76.52%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGLX.OL Yearly ROA, ROE, ROICAGLX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

AGLX's Profit Margin of 1355.78% is amongst the best of the industry. AGLX outperforms 100.00% of its industry peers.
The Gross Margin of AGLX (4.51%) is worse than 79.07% of its industry peers.
In the last couple of years the Gross Margin of AGLX has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1355.78%
GM 4.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.6%
GM growth 5YN/A
AGLX.OL Yearly Profit, Operating, Gross MarginsAGLX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 500 1K 1.5K

More info and screens

8

2. Health

2.1 Basic Checks

AGLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AGLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AGLX.OL Yearly Shares OutstandingAGLX.OL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
AGLX.OL Yearly Total Debt VS Total AssetsAGLX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

AGLX has an Altman-Z score of 29.08. This indicates that AGLX is financially healthy and has little risk of bankruptcy at the moment.
AGLX's Altman-Z score of 29.08 is amongst the best of the industry. AGLX outperforms 100.00% of its industry peers.
AGLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.08
ROIC/WACCN/A
WACC8.66%
AGLX.OL Yearly LT Debt VS Equity VS FCFAGLX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 3.84 indicates that AGLX has no problem at all paying its short term obligations.
The Current ratio of AGLX (3.84) is better than 95.35% of its industry peers.
AGLX has a Quick Ratio of 3.84. This indicates that AGLX is financially healthy and has no problem in meeting its short term obligations.
AGLX's Quick ratio of 3.84 is amongst the best of the industry. AGLX outperforms 95.35% of its industry peers.
Industry RankSector Rank
Current Ratio 3.84
Quick Ratio 3.84
AGLX.OL Yearly Current Assets VS Current LiabilitesAGLX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 441.41% over the past year.
Looking at the last year, AGLX shows a very negative growth in Revenue. The Revenue has decreased by -62.18% in the last year.
AGLX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.78% yearly.
EPS 1Y (TTM)441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.77%
Revenue 1Y (TTM)-62.18%
Revenue growth 3Y10.78%
Revenue growth 5YN/A
Sales Q2Q%-94.49%

3.2 Future

AGLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.22% yearly.
AGLX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.60% yearly.
EPS Next Y17.54%
EPS Next 2Y17.11%
EPS Next 3Y20.2%
EPS Next 5Y31.22%
Revenue Next Year-8.01%
Revenue Next 2Y54.62%
Revenue Next 3Y-5.96%
Revenue Next 5Y20.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGLX.OL Yearly Revenue VS EstimatesAGLX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
AGLX.OL Yearly EPS VS EstimatesAGLX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.53, the valuation of AGLX can be described as very cheap.
95.35% of the companies in the same industry are more expensive than AGLX, based on the Price/Earnings ratio.
AGLX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
AGLX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 2.53
Fwd PE N/A
AGLX.OL Price Earnings VS Forward Price EarningsAGLX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGLX.OL Per share dataAGLX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

AGLX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AGLX's earnings are expected to grow with 20.20% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y17.11%
EPS Next 3Y20.2%

More info and screens

0

5. Dividend

5.1 Amount

AGLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGILYX ASA

OSL:AGLX (4/25/2025, 7:00:00 PM)

26

-0.1 (-0.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)04-29 2025-04-29/amc
Inst Owners28.67%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap2.87B
Analysts84.44
Price Target38.25 (47.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6%
EPS NY rev (3m)1.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)202.66%
Valuation
Industry RankSector Rank
PE 2.53
Fwd PE N/A
P/S 43.56
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)10.29
EY39.58%
EPS(NY)-1.52
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS0.6
BVpS10.58
TBVpS10.32
PEG (NY)0.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 72.71%
ROE 76.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1355.78%
GM 4.51%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.6%
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 290.8%
Cap/Sales 43.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.84
Quick Ratio 3.84
Altman-Z 29.08
F-Score4
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)399.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)51.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.77%
EPS Next Y17.54%
EPS Next 2Y17.11%
EPS Next 3Y20.2%
EPS Next 5Y31.22%
Revenue 1Y (TTM)-62.18%
Revenue growth 3Y10.78%
Revenue growth 5YN/A
Sales Q2Q%-94.49%
Revenue Next Year-8.01%
Revenue Next 2Y54.62%
Revenue Next 3Y-5.96%
Revenue Next 5Y20.6%
EBIT growth 1Y-1.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.46%
EBIT Next 3Y24.01%
EBIT Next 5Y36.27%
FCF growth 1Y-3.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.27%
OCF growth 3YN/A
OCF growth 5YN/A